Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma renin substrate during lithium treatment.

A Kierkegaard-Hansen, E B Pedersen, S Darling

    International Pharmacopsychiatry
    |January 1, 1977
    PubMed
    Summary

    Lithium treatment does not affect plasma renin substrate levels in patients with manic-depressive illness. Studies found no significant changes in renin substrate during lithium therapy or compared to control groups.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prenatal exposure to airborne polychlorinated biphenyl congeners and male reproductive health.

    Human reproduction (Oxford, England)·2022
    Same author

    Mental health and wellbeing coordinators in primary schools to support student mental health: protocol for a quasi-experimental cluster study.

    BMC public health·2021
    Same author

    A Comparison of Urine Dilution Ability between Adult Dominant Polycystic Kidney Disease, Other Chronic Kidney Diseases, and Healthy Control Subjects: A Case-Control Study.

    International journal of nephrology·2020
    Same author

    Urine concentration ability is reduced to the same degree in adult dominant polycystic kidney disease compared with other chronic kidney diseases in the same CKD-stage and lower THAN in healthy control subjects - a CASE control study.

    BMC nephrology·2020
    Same author

    Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.

    BMC nephrology·2019
    Same author

    Lipid-modified G4-decoy oligonucleotide anchored to nanoparticles: delivery and bioactivity in pancreatic cancer cells.

    Scientific reports·2016

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Psychiatry

    Background:

    • Lithium is a common treatment for manic-depressive illness.
    • Animal studies suggested potential effects of lithium on the renin-angiotensin system.
    • The impact of lithium on plasma renin substrate in humans was previously unclear.

    Purpose of the Study:

    • To investigate the effect of lithium treatment on plasma renin substrate levels in patients with manic-depressive illness.
    • To determine if long-term lithium exposure alters plasma renin substrate.
    • To explore potential correlations between serum lithium concentrations and plasma renin substrate.

    Main Methods:

    • A longitudinal study measured plasma renin substrate in 9 patients before and during 3 months of lithium treatment.
    • A cross-sectional study compared plasma renin substrate in 18 long-term lithium-treated patients (2-20 years) with 11 healthy controls.
    • Serum lithium concentrations were measured and correlated with plasma renin substrate levels.

    Main Results:

    • Plasma renin substrate levels did not significantly change from baseline during the 3-month longitudinal lithium treatment.
    • No significant difference in plasma renin substrate was observed between patients on long-term lithium treatment and control subjects.
    • No correlation was found between serum lithium concentrations and plasma renin substrate values.

    Conclusions:

    • Lithium treatment appears to have no significant effect on plasma renin substrate levels in patients with manic-depressive illness.
    • Long-term lithium exposure does not alter plasma renin substrate concentrations.
    • These findings suggest the renin-angiotensin system's substrate component is unaffected by therapeutic lithium use.

    Related Experiment Videos